Summary

HNY Research projects that the Quetiapine Fumarate market size will grow from 155.3 Million USD in 2025 to 194.25 Million USD by 2031, at an estimated CAGR of 3.8%. The base year considered for the study is 2025, and the market size is projected from 2026 to 2031.
For 2025 regional market size, the North America market size was 32.94 Million USD, the Europe market size was 27.92 Million USD, and the Asia market size was 34.17 Million USD.
This report presents a detailed and holistic analysis of the global Quetiapine Fumarate market. It integrates quantitative data with qualitative insights to equip readers with the necessary information for strategic planning, competitive assessment, market positioning, and data-driven decision-making.
All market sizes, estimates, and forecasts are expressed in terms of output/shipments and revenue. With 2025 serving as the base year, the report provides historical context from 2020. and projections up to 2031. It includes a complete segmentation of the global market, along with regional market sizes analyzed by type, application, and key industry participants.
Further enriching the analysis, the report outlines the competitive environment, offering profiles of prominent players and their market standings. It also explores key technological advancements and recent developments in product offerings.
Ultimately, this report serves as a vital resource for Quetiapine Fumarate manufacturers, prospective entrants, and other stakeholders within the industry value chain. It supplies comprehensive data on revenues, production, and average pricing for the overall market and its sub-segments, detailed by company, product type, application, and geographic region.

By Market Players:
AstraZeneca
Intas
TAPI
Accord
Hexal
Dr.Reddy's
Lupin
Sun Pharmaceutical
Hunan Dongting Pharm
SuZhou NO.4 Phamaceutical Factory
Fuan Pharmaceutical
Zhejiang Supor Pharmaceuticals
Zhejiang Huahai Pharmaceutical

By Type
Immediate Release Tablets
Extended Release Tablets

By Application
Adult
Others

By Regions/Countries:
North America
East Asia
Europe
South Asia
Southeast Asia
Middle East
Africa
Oceania
South America

Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Quetiapine Fumarate Revenue
1.4 Market Analysis by Type
1.4.1 Global Quetiapine Fumarate Market Size Growth Rate by Type: 2026-2031
1.4.2 Immediate Release Tablets
1.4.3 Extended Release Tablets
1.5 Market by Application
1.5.1 Global Quetiapine Fumarate Market Share by Application: 2026-2031
1.5.2 Adult
1.5.3 Others
1.6 Study Objectives
1.7 Overview of Global Quetiapine Fumarate Market
1.7.1 Global Quetiapine Fumarate Market Status and Outlook (2020-2031)
1.7.2 North America
1.7.3 East Asia
1.7.4 Europe
1.7.5 South Asia
1.7.6 Southeast Asia
1.7.7 Middle East
1.7.8 Africa
1.7.9 Oceania
1.7.10 South America
1.7.11 Rest of the World
2 Manufacturing Cost Structure Analysis
2.1 Manufacturing Cost Structure Analysis of Quetiapine Fumarate
2.2 Industry Chain Structure of Quetiapine Fumarate
3 Market Competition by Manufacturers
3.1 Global Quetiapine Fumarate Production Capacity Market Share by Manufacturers (2020-2025)
3.2 Global Quetiapine Fumarate Revenue Market Share by Manufacturers (2020-2025)
3.3 Global Quetiapine Fumarate Average Price by Manufacturers (2020-2025)
4 Quetiapine Fumarate Regional Market Analysis
4.1 Quetiapine Fumarate Production by Regions
4.1.1 Global Quetiapine Fumarate Production by Regions (2020-2025)
4.1.2 Global Quetiapine Fumarate Revenue by Regions
4.2 Quetiapine Fumarate Consumption by Regions
4.3 North America Quetiapine Fumarate Market Analysis
4.3.1 North America Quetiapine Fumarate Production
4.3.2 North America Quetiapine Fumarate Revenue
4.3.3 Key Manufacturers in North America
4.3.4 North America Quetiapine Fumarate Import and Export
4.4 East Asia Quetiapine Fumarate Market Analysis
4.4.1 East Asia Quetiapine Fumarate Production
4.4.2 East Asia Quetiapine Fumarate Revenue
4.4.3 Key Manufacturers in East Asia
4.4.4 East Asia Quetiapine Fumarate Import & Export
4.5 Europe Quetiapine Fumarate Market Analysis
4.5.1 Europe Quetiapine Fumarate Production
4.5.2 Europe Quetiapine Fumarate Revenue
4.5.3 Key Manufacturers in Europe
4.5.4 Europe Quetiapine Fumarate Import & Export
4.6 South Asia Quetiapine Fumarate Market Analysis
4.6.1 South Asia Quetiapine Fumarate Production
4.6.2 South Asia Quetiapine Fumarate Revenue
4.6.3 Key Manufacturers in South Asia
4.6.4 South Asia Quetiapine Fumarate Import & Export
4.7 Southeast Asia Quetiapine Fumarate Market Analysis
4.7.1 Southeast Asia Quetiapine Fumarate Production
4.7.2 Southeast Asia Quetiapine Fumarate Revenue
4.7.3 Key Manufacturers in Southeast Asia
4.7.4 Southeast Asia Quetiapine Fumarate Import & Export
4.8 Middle East Quetiapine Fumarate Market Analysis
4.8.1 Middle East Quetiapine Fumarate Production
4.8.2 Middle East Quetiapine Fumarate Revenue
4.8.3 Key Manufacturers in Middle East
4.8.4 Middle East Quetiapine Fumarate Import & Export
4.9 Africa Quetiapine Fumarate Market Analysis
4.9.1 Africa Quetiapine Fumarate Production
4.9.2 Africa Quetiapine Fumarate Revenue
4.9.3 Key Manufacturers in Africa
4.9.4 Africa Quetiapine Fumarate Import & Export
4.10 Oceania Quetiapine Fumarate Market Analysis
4.10.1 Oceania Quetiapine Fumarate Production
4.10.2 Oceania Quetiapine Fumarate Revenue
4.10.3 Key Manufacturers in Oceania
4.10.4 Oceania Quetiapine Fumarate Import & Export
4.11 South America Quetiapine Fumarate Market Analysis
4.11.1 South America Quetiapine Fumarate Production
4.11.2 South America Quetiapine Fumarate Revenue
4.11.3 Key Manufacturers in South America
4.11.4 South America Quetiapine Fumarate Import & Export
5 Quetiapine Fumarate Sales Market by Type (2020-2031)
5.1 Global Quetiapine Fumarate Historic Market Size by Type (2020-2025)
5.2 Global Quetiapine Fumarate Forecasted Market Size by Type (2026-2031)
6 Quetiapine Fumarate Consumption Market by Application(2020-2031)
6.1 Global Quetiapine Fumarate Historic Market Size by Application (2020-2025)
6.2 Global Quetiapine Fumarate Forecasted Market Size by Application (2026-2031)
7 Company Profiles and Key Figures in Quetiapine Fumarate Business
7.1 AstraZeneca
7.1.1 AstraZeneca Company Profile
7.1.2 AstraZeneca Quetiapine Fumarate Product Specification
7.1.3 AstraZeneca Quetiapine Fumarate Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.2 Intas
7.2.1 Intas Company Profile
7.2.2 Intas Quetiapine Fumarate Product Specification
7.2.3 Intas Quetiapine Fumarate Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.3 TAPI
7.3.1 TAPI Company Profile
7.3.2 TAPI Quetiapine Fumarate Product Specification
7.3.3 TAPI Quetiapine Fumarate Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.4 Accord
7.4.1 Accord Company Profile
7.4.2 Accord Quetiapine Fumarate Product Specification
7.4.3 Accord Quetiapine Fumarate Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.5 Hexal
7.5.1 Hexal Company Profile
7.5.2 Hexal Quetiapine Fumarate Product Specification
7.5.3 Hexal Quetiapine Fumarate Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.6 Dr.Reddy's
7.6.1 Dr.Reddy's Company Profile
7.6.2 Dr.Reddy's Quetiapine Fumarate Product Specification
7.6.3 Dr.Reddy's Quetiapine Fumarate Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.7 Lupin
7.7.1 Lupin Company Profile
7.7.2 Lupin Quetiapine Fumarate Product Specification
7.7.3 Lupin Quetiapine Fumarate Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.8 Sun Pharmaceutical
7.8.1 Sun Pharmaceutical Company Profile
7.8.2 Sun Pharmaceutical Quetiapine Fumarate Product Specification
7.8.3 Sun Pharmaceutical Quetiapine Fumarate Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.9 Hunan Dongting Pharm
7.9.1 Hunan Dongting Pharm Company Profile
7.9.2 Hunan Dongting Pharm Quetiapine Fumarate Product Specification
7.9.3 Hunan Dongting Pharm Quetiapine Fumarate Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.10 SuZhou NO.4 Phamaceutical Factory
7.10.1 SuZhou NO.4 Phamaceutical Factory Company Profile
7.10.2 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product Specification
7.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.11 Fuan Pharmaceutical
7.11.1 Fuan Pharmaceutical Company Profile
7.11.2 Fuan Pharmaceutical Quetiapine Fumarate Product Specification
7.11.3 Fuan Pharmaceutical Quetiapine Fumarate Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.12 Zhejiang Supor Pharmaceuticals
7.12.1 Zhejiang Supor Pharmaceuticals Company Profile
7.12.2 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product Specification
7.12.3 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.13 Zhejiang Huahai Pharmaceutical
7.13.1 Zhejiang Huahai Pharmaceutical Company Profile
7.13.2 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product Specification
7.13.3 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Production Capacity, Revenue, Price and Gross Margin (2020-2025)
8 Production and Supply Forecast
8.1 Global Forecasted Production of Quetiapine Fumarate (2026-2031)
8.2 Global Forecasted Revenue of Quetiapine Fumarate (2026-2031)
8.3 Global Forecasted Price of Quetiapine Fumarate (2020-2031)
8.4 Global Forecasted Production of Quetiapine Fumarate by Region (2026-2031)
8.4.1 North America Quetiapine Fumarate Production, Revenue Forecast (2026-2031)
8.4.2 East Asia Quetiapine Fumarate Production, Revenue Forecast (2026-2031)
8.4.3 Europe Quetiapine Fumarate Production, Revenue Forecast (2026-2031)
8.4.4 South Asia Quetiapine Fumarate Production, Revenue Forecast (2026-2031)
8.4.5 Southeast Asia Quetiapine Fumarate Production, Revenue Forecast (2026-2031)
8.4.6 Middle East Quetiapine Fumarate Production, Revenue Forecast (2026-2031)
8.4.7 Africa Quetiapine Fumarate Production, Revenue Forecast (2026-2031)
8.4.8 Oceania Quetiapine Fumarate Production, Revenue Forecast (2026-2031)
8.4.9 South America Quetiapine Fumarate Production, Revenue Forecast (2026-2031)
8.4.10 Rest of the World Quetiapine Fumarate Production, Revenue Forecast (2026-2031)
8.5 Forecast by Type and by Application (2026-2031)
8.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2026-2031)
8.5.2 Global Forecasted Consumption of Quetiapine Fumarate by Application (2026-2031)
9 Consumption and Demand Forecast
9.1 North America Forecasted Consumption of Quetiapine Fumarate by Country
9.2 East Asia Market Forecasted Consumption of Quetiapine Fumarate by Country
9.3 Europe Market Forecasted Consumption of Quetiapine Fumarate by Countriy
9.4 South Asia Forecasted Consumption of Quetiapine Fumarate by Country
9.5 Southeast Asia Forecasted Consumption of Quetiapine Fumarate by Country
9.6 Middle East Forecasted Consumption of Quetiapine Fumarate by Country
9.7 Africa Forecasted Consumption of Quetiapine Fumarate by Country
9.8 Oceania Forecasted Consumption of Quetiapine Fumarate by Country
9.9 South America Forecasted Consumption of Quetiapine Fumarate by Country
9.10 Rest of the world Forecasted Consumption of Quetiapine Fumarate by Country
10 Marketing Channel, Distributors and Customers
10.1 Marketing Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities and Drivers
11.3 Challenges
11.4 Porter's Five Forces Analysis
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer